Skip to menu Skip to content Skip to footer
Professor

Andrew Clouston

Email: 

Overview

Availability

Professor Andrew Clouston is:
Available for supervision

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Royal College of Pathologists of Australasia, Royal College of Pathologists of Australasia

Works

Search Professor Andrew Clouston’s works on UQ eSpace

380 works between 1993 and 2025

41 - 60 of 380 works

2019

Journal Article

Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract

Gartlan, Kate H., Koyama, Motoko, Lineburg, Katie E., Chang, Karshing, Ensbey, Kathleen S., Kuns, Rachel D., Henden, Andrea S., Samson, Luke D., Clouston, Andrew D., Lopez, Angel F., MacDonald, Kelli P. A. and Hill, Geoffrey R. (2019). Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract. Blood Advances, 3 (19), 2859-2865. doi: 10.1182/bloodadvances.2019000053

Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract

2019

Journal Article

IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling

Wilkinson, Andrew N., Chang, Karshing, Kuns, Rachel D., Henden, Andrea S., Minnie, Simone A., Ensbey, Kathleen S., Clouston, Andrew D., Zhang, Ping, Koyama, Motoko, Hidalgo, Juan, Rose-John, Stefan, Varelias, Antiopi, Vuckovic, Slavica, Gartlan, Kate H. and Hill, Geoffrey R. (2019). IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling. Blood, 134 (23), 2092-2106. doi: 10.1182/blood.2019000396

IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling

2019

Conference Publication

Argininosuccinate synthase 1 immunomarker identifies sonic hedgehog hepatocellular adenomas: its use in clinical practice

Sala, Margaux, Gonzales, Dephine, Teste-Lassere, Thierry, Dugot-Senant, Nathalie, Paradis, Valerie, Di-Tommaso, Sylvaine, Dupuy, Jean William, Pitard, Vincent, Dourthe, Cyril, Sempoux, Christine, Gouw, Annette, Ferrell, Linda, Clouston, Andrew D., Miller, Gregory, Nakanuma, Yasuni, Sciarra, Amedeo, Yeh, Matthew M., Thung, Swan N., Quaglia, Alberto, Han, Jing, Yuan, Ji, Fan, Cathy, Crawford, James M., Possenti, Laurent, Balabaud, Charles, Bioulac-Sage, Paulette, Raymond, Anne Aurelie and Saltel, Frederic (2019). Argininosuccinate synthase 1 immunomarker identifies sonic hedgehog hepatocellular adenomas: its use in clinical practice. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, Boston, MA, United States, 8-12 November 2019. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1002/hep.30941

Argininosuccinate synthase 1 immunomarker identifies sonic hedgehog hepatocellular adenomas: its use in clinical practice

2019

Conference Publication

A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD

McKillen, B., Elangovan, H., Horsfall, L., Patel, P., Hayward, K., Clouston, A., Radford-Smith, D., Valery, P., Britton, L., Brown, N., Bernard, A. and Powell, E. (2019). A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA Australia, 8–10 September 2019. Richmond, VIC Australia: Wiley-Blackwell.

A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD

2019

Journal Article

Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores

Janubhai Patel, Preya, Chieh-Yu Cheng, Johnson, Banh, Xuan, Gracen, Lucy, Radford-Smith, Daniel, Hossain, Fabrina, Horsfall, Leigh Ula, Lee Hayward, Kelly, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine Anne, Russell, Anthony William, Valery, Patricia Casarolli, Clouston, Andrew Donald, Irvine, Katharine Margaret, Bernard, Anne and Powell, Elizabeth Ellen (2019). Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores. Clinical Gastroenterology and Hepatology, 18 (3), 710-718.e4. doi: 10.1016/j.cgh.2019.07.036

Clinically significant fibrosis is associated with longitudinal increases in fibrosis-4 and nonalcoholic fatty liver disease fibrosis scores

2019

Journal Article

Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation

Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Gupta, Praveer K., Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J., Fairlie, David P. and Iyer, Abishek (2019). Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation. British Journal of Pharmacology, 176 (19) bph.14768, 3775-3790. doi: 10.1111/bph.14768

Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic Type 2 inflammation

2019

Conference Publication

Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology

Koyama, Motoko, Mukhopadhyay, Pamela, Schuster, Iona S., Henden, Andrea S., Hülsdünker, Jan, Varelias, Antiopi, Vetizou, Marie, Kuns, Rachel D., Robb, Renee J., Zhang, Ping, Blazar, Bruce R., Thomas, Ranjeny, Begun, Jakob, Waddell, Nicola, Trinchieri, Giorgio, Zeiser, Robert, Clouston, Andrew D., Degli-Esposti, Mariapia A. and Hill, Geoffrey R. (2019). Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology. Immunology 2019™ Meeting, San Diego, CA United States, 9-13 May 2019. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.202.supp.69.38

Immune responses to the microbiome tune MHC class II antigen presentation by the intestinal epithelium to control gut pathology

2019

Journal Article

Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial

Stevenson, Andrew R. L., Solomon, Michael J., Brown, Christopher S. B., Lumley, John W., Hewett, Peter, Clouston, Andrew D., Gebski, Val J., Wilson, Kate, Hague, Wendy, Simes, John, on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG) ALaCaRT investigators and Clark, David (2019). Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial. Annals of Surgery, 269 (4), 596-602. doi: 10.1097/SLA.0000000000003021

Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial

2019

Conference Publication

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

Iyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J. and Fairlie, David P. (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. Experimental Biology Meeting (EB), Orlando Fl, Apr 06-09, 2019. HOBOKEN: WILEY.

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

2019

Conference Publication

Myxoglobulosis of the appendix: A case series and literature review

Vidler, J., Walker, N., Clouston, A. and Brown, I. (2019). Myxoglobulosis of the appendix: A case series and literature review. Pathology Update 2019, Melbourne, VIC Australia, 22-24 February 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2018.09.031

Myxoglobulosis of the appendix: A case series and literature review

2019

Conference Publication

Endoscopically resected colorectal polyps ≤10 mm are not always innocuous: caution against a routine discard policy

Boyd, Grace, Clouston, Andrew, Miller, Gregory, Bettington, Mark, Rosty, Christophe and Brown, Ian (2019). Endoscopically resected colorectal polyps ≤10 mm are not always innocuous: caution against a routine discard policy. Pathology Update 2019, Melbourne, VIC Australia, 22-24 February 2019. Elsevier. doi: 10.1016/j.pathol.2018.12.176

Endoscopically resected colorectal polyps ≤10 mm are not always innocuous: caution against a routine discard policy

2018

Conference Publication

Macrophage colony stimulating factor (CSF1) promotes regression of advanced fibrosis and liver regeneration in mice

Irvine, Katharine, Genz, Berit, Clouston, Andrew D. and Hume, David (2018). Macrophage colony stimulating factor (CSF1) promotes regression of advanced fibrosis and liver regeneration in mice. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San Francisco, CA USA, 9-13 November 2018. Hoboken, NJ USA: Wiley.

Macrophage colony stimulating factor (CSF1) promotes regression of advanced fibrosis and liver regeneration in mice

2018

Journal Article

Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria

Miller, Gregory C., Campbell, Catherine M., Manoharan, Bavahuna, Bryant, Richard, Cavallucci, David, O'Rourke, Nicholas and Clouston, Andrew D. (2018). Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria. Pathology, 50 (6), 593-599. doi: 10.1016/j.pathol.2018.05.003

Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria

2018

Journal Article

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Bernard, Anne, Brown, Nigel Neil, Lampe, Guy, Buck, Lyndall, Saad, Nivene, Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Rosenberg, William and Powell, Elizabeth Ellen (2018). A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatology Communications, 2 (8), 893-905. doi: 10.1002/hep4.1208

A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care

2018

Journal Article

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, Divya, Irvine, Katharine M., Lukowski, Samuel W., Horsfall, Leigh U., Loh, Zhixuan, Clouston, Andrew D., Patel, Preya J., Fagan, Kevin J., Iyer, Abishek, Lampe, Guy, Stow, Jennifer L., Schroder, Kate, Fairlie, David P., Powell, Joseph E., Powell, Elizabeth E. and Sweet, Matthew J. (2018). Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight, 3 (14) e120274. doi: 10.1172/jci.insight.120274

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

2018

Conference Publication

Ubiquitin Ligase MARCH8 attenuates Graft versus Host Disease via Regulation of Gut Epithelial Cell Surface MHC II Expression

Lineburg, Katie E., Le Texier, Laetitia, Melino, Michelle, Wang, Ran, Clouston, Andrew, Blazar, Bruce R., McGuckin, Michael A., Villadangos, Jose A., Mintern, Justine D. and MacDonald, Kelli P. A. (2018). Ubiquitin Ligase MARCH8 attenuates Graft versus Host Disease via Regulation of Gut Epithelial Cell Surface MHC II Expression. 27th International Congress of the Transplantation-Society (TTS), Madrid, Spain, 30 June-5 July 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1097/01.tp.0000543013.84163.3a

Ubiquitin Ligase MARCH8 attenuates Graft versus Host Disease via Regulation of Gut Epithelial Cell Surface MHC II Expression

2018

Journal Article

Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control

Patel, Preya Janubhai, Hossain, Fabrina, Horsfall, Leigh Ula, Banh, Xuan, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Valery, Patricia Casarolli, Irvine, Katharine Margaret, Clouston, Andrew Donald, Stuart, Katherine Anne, Russell, Anthony William and Powell, Elizabeth Ellen (2018). Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. Journal of Diabetes and its Complications, 32 (8), 799-804. doi: 10.1016/j.jdiacomp.2018.05.008

Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control

2018

Conference Publication

Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon

Varelias, Antiopi, Bunting, Mark, Ormerod, Kate, Koyama, Motoko, Olver, Stuart, Straube, Jasmin, Kuns, Rachel, Robb, Renee, Henden, Andrea, Cooper, Leanne, Lachner, Nancy, Gartlan, Kate, Lantz, Olivier J., Kjer-Nielsen, Lars, Mak, Jeffrey, Fairlie, David, Clouston, Andrew, McCluskey, James, Rossjohn, Jamie, Lane, Steven, Hugenholtz, Phil and Hill, Geoff (2018). Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon. Immunology 2018™ Meeting, Austin, TX United States, 4-8 May 2018. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.200.supp.55.15

Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon

2018

Journal Article

Recipient mucosal-associated invariant T cells control GVHD within the colon

Varelias, Antiopi, Bunting, Mark D., Ormerod, Kate L., Koyama, Motoko, Olver, Stuart D., Straube, Jasmin, Kuns, Rachel D., Robb, Renee J., Henden, Andrea S., Cooper, Leanne, Lachner, Nancy, Gartlan, Kate H., Lantz, Olivier, Kjer-Nielsen, Lars, Mak, Jeffrey Y. W., Fairlie, David P., Clouston, Andrew D., McCluskey, James, Rossjohn, Jamie, Lane, Steven W., Hugenholtz, Philip and Hill, Geoffrey R. (2018). Recipient mucosal-associated invariant T cells control GVHD within the colon. Journal of Clinical Investigation, 128 (5), 1919-1936. doi: 10.1172/JCI91646

Recipient mucosal-associated invariant T cells control GVHD within the colon

2018

Journal Article

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Burt, Alastair D, Alves, Venâncio, Bedossa, Pierre, Clouston, Andrew, Guido, Maria, Hübscher, Stefan, Kakar, Sanjay, Ng, Irene, Park, Young N, Reeves, Helen, Wyatt, Judith, Yeh, Matthew M and Ellis, David W (2018). Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 73 (3), 369-385. doi: 10.1111/his.13520

Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

Funding

Past funding

  • 2019 - 2022
    CSF1 Therapy for Chronic Liver Disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2019
    A La CaRT: Australasian Laparoscopic Cancer of the Rectum Trial. A phase III prospective randomised trial comparing laparoscopic-assisted ... (NHMRC Project Grant administered by University of Sydney)
    University of Sydney
    Open grant
  • 2015 - 2016
    Identifying Protective v Pathogenic Macrophages in Chronic Liver Disease: Critical for Macrophage-Targeted Therapy
    PA Research Foundation
    Open grant
  • 2013 - 2014
    Targeting the Wnt Pathway: Implication for Chronic Liver disease
    PA Research Foundation
    Open grant
  • 2013 - 2015
    Defining the role of MMP-9-expressing macrophages in liver injury in chronic liver disease
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    Monocytes/macrophages in chronic liver diseases: cross-talk with hepatocytes and nonparenchymal cells and role in progressive liver injury
    NHMRC Project Grant
    Open grant
  • 2008 - 2010
    Role of obesity in impaired treatment response in chronic hepatitis C: mechanisms and therapeutic strategies
    NHMRC Project Grant
    Open grant
  • 2007 - 2009
    Hepatocyte replicative arrest, hepatic progenitor cells and the ductular reaction in hepatic fibrogenesis
    NHMRC Project Grant
    Open grant
  • 2006 - 2009
    The Role Of Hepatic Progenitor Cells And A Ductular Reaction In Disease Progression In Non-Alcoholic Fatty Liver Disease
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005
    The effect of obesity on liver function in children who are long term liver transplant recipients
    Royal Children's Hospital Foundation
    Open grant
  • 2005 - 2007
    The role of steatosis in promoting cellular injury and fibrogenesis in human liver disease
    NHMRC Project Grant
    Open grant
  • 2004 - 2005
    The Effect Of Alcohol On Hepatitis C-Induced Liver Disease
    Australian Brewers' Foundation
    Open grant
  • 2002 - 2004
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    NHMRC Project Grant
    Open grant
  • 2002
    Strategies to monitor graft acceptance following human liver transplantation
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001 - 2002
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Mayne Bequest Fund
    Open grant
  • 2001
    Fibrosis after liver transplantation - role of the renin angiotensin system
    Royal Children's Hospital Foundation
    Open grant
  • 2001
    Hepatitis C virus and the host: Viral effects on lipid metabolism and fibrogenesis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2001
    Investigation of the role of the renin-angiotensin system in hepatic fibrosis
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2000
    Investigation of the relationship between steatosis, lipid peroxidation and fibrosis in chronic hepatitis C
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1999
    Donor leucocytes contribute to liver allograft acceptance: investigation of a mechanism
    Royal Children's Hospital Foundation
    Open grant
  • 1999
    Fine needle aspiration of liver grafts to monitor apoptosis of graft infiltrating leucocytes
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1998
    Cytokine modulation ofliver associated leucocyte proliferation and cytotoxicity
    Royal Children's Hospital
    Open grant
  • 1997
    Characterisation of leucocytes derived from human liver preservation perfusate: a new form of donor-specific transfusion?
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1997
    Frequency and distribution of cytokine expression in liver allograft rejection
    University of Queensland New Staff Research Grant
    Open grant
  • 1997
    Mechanisms by which liver-derived leucocytes may promote human graft acceptance
    Royal Children's Hospital Foundation
    Open grant
  • 1996
    Characterization of chimeric leucocytes following human liver transplantation
    Mayne Bequest Fund
    Open grant

Supervision

Availability

Professor Andrew Clouston is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Andrew Clouston's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au